Reading IFF? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IFF free→Reading IFF? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IFF free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-06-15
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong. Earnings quality is fragile, meaning profits lack cash support. Management's recent track record has been steady. Risk is moderate, and the sector backdrop is a headwind. Peer multiples imply a price about 26% below where it trades (it looks expensive on this basis); the read is fair, but weakening. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $78.38. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $78 IFF trades at 18× p/e, below its 21× p/e peer median. Our $59 fair value sits above the price; low confidence. Analysts: $75–$95. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 33% near-term growth, well above our forecast of about -8%. This describes what's priced in, not a forecast of the move.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Crisis) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Materials names rated strong grew net income 63% of the time over the next year (vs 54% for the rest of the cohort, n=1093).
Over the trailing year it converted 1.18x of net income into operating cash flow. Historically, Materials names rated fragile grew net income 46% of the time over the next year (vs 57% for the rest of the cohort, n=988).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.12 → $1.12 (+0.2% / 30d). 1 raised, 9 cut, 12 covering analysts.
0 upgrades, 0 downgrades / 30d. 80% of analysts rate Buy.
1 positive, 0 negative / 30d. See F4 management tile for the event list.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$132.
How much price usually moves either way.
On a bad day, this stock has moved -$275.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,262.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Closing the sale will mark a key step in IFF's portfolio transformation. It will help focus on higher-margin businesses and improve cash flow.
Confirms:The deal will close by the end of Q2 2027. There will be no delays.
Disproves:The sale is delayed beyond Q2 2027 or fails to close due to regulatory issues.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for IFF yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Entry into a Material Definitive Agreement. On May 28, 2026, International Flavors & Fragrances Inc. (“IFF” or the “Company”) entered into a Transaction Agreement (the “Transaction Agreement”) with Foxtrot US Bidco, Inc. (“Buyer”) and Foxtrot Midco LP (“Buyer Parent”), each affiliates of CVC Capital Partners, pursuant to which, subject to the satisfaction of customary closing conditions set forth in the Transaction Agreement, IFF has agreed to sell to Buyer the Company’s Food Ingredients busi…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$75.00 – $95.00 (median $90.00) · 6 analysts · as of 2026-05-07
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Specialty Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
IFF International Flavors & Fragrances | Typical Show detailsSector percentile: 56 of 100 | full | moderate |
SHW Sherwin-Williams | Typical Show detailsSector percentile: 67 of 100 | full | moderate |
ECL Ecolab | Above typical Show detailsSector percentile: 83 of 100 | expensive | moderate |
PPG PPG Industries | Above typical Show detailsSector percentile: 90 of 100 | fair | moderate |
LYB LyondellBasell | Typical Show detailsSector percentile: 55 of 100 | — | moderate |
10 material management or governance events in the past 24 months, led by executive changes. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 54% for the rest of the cohort, n=272).
Not investment advice. As of 2026-06-15.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
IFF is focusing on optimizing its portfolio by divesting non-core assets, including the Food Ingredients segment.
IFF aims to enhance financial performance by advancing its innovation pipeline and serving customers with leading solutions.
IFF is working to improve its financial flexibility through strategic divestitures and capital allocation.
Why it matters: Sales growth in Q1 2026 shows IFF's recovery. It also shows their ability to improve financial results.
Confirms:Q1 2026 sales growth reported at 1% to 4% as guided by management.
Disproves:Sales growth reported below 1% in Q1 2026.
Why it matters: Growth in adjusted operating EBITDA shows they manage costs well. It also shows better operations.
Confirms:Adjusted operating EBITDA grew by 3% to 8% from last year in 2026.
Disproves:Adjusted operating EBITDA grew by less than 3% from last year in 2026.
Why it matters: Better margins show good cost management. This means the company is running well despite selling parts.
Confirms:Adjusted EBITDA margin is above 20% for Q2 2026.
Disproves:Adjusted EBITDA margin falls below 18% for Q2 2026.
Why it matters: These indicators can affect IFF's sales and how it operates.
Confirms one read:The Consumer Price Index shows inflation going down. This helps lower IFF's costs.
Confirms the other:The Producer Price Index shows inflation going up. This raises IFF's cost pressures.
Why it matters: Strong cash flow helps IFF invest and manage debt well.
Confirms:Cash flow from operations exceeds $850 million in Q2 2026.
Disproves:Cash flow from operations falls below $850 million in Q2 2026.
Why it matters: Reducing debt will make IFF's balance sheet stronger. This will help with financial choices.
Confirms:Management shares a clear plan to reduce debt after the sale.
Disproves:There are no big updates on debt reduction plans after the sale.
Why it matters: How IFF uses the proceeds will impact its financial flexibility and growth potential. Investors will want to see a focus on debt reduction and reinvestment.
Confirms one read:IFF shares a clear plan. It focuses on paying off debt and smart investments.
Confirms the other:IFF fails to provide a detailed plan or focuses on low-return investments.
Why it matters: If growth is higher than expected, it shows strong performance. This would help IFF's financial plans.
Confirms:Q2 2026 sales growth reported above 4% year over year.
Disproves:Sales growth is below 1% year over year. This shows ongoing problems.
Results of Operations and Financial Condition Attached and being furnished hereby as Exhibit 99.1 is a copy of a press release of International Flavors & Fragrances Inc. (“IFF” or the “Company”), dated May 5, 2026, reporting IFF’s financial results for the quarter ended March 31, 2026. A live webcast to discuss the Company’s first quarter 2026 financial results will be held on May 6, 2026, at 9:00 a.m. ET. The webcast and accompanying slide presentation may be accessed on the Company’s IR web…
Results of Operations and Financial Condition Attached and being furnished hereby as Exhibit 99.1 is a copy of a press release of International Flavors & Fragrances Inc. (“IFF” or the “Company”), dated February 11, 2026 , reporting IFF’s financial results for the quarter and fiscal year ended December 31, 2025. A live webcast to discuss the Company’s fourth quarter and full year 2025 financial results and outlook for 2026 will be held on February 12, 2026, at 9:00 a.m. ET. The webcast and acc…
Results of Operations and Financial Condition Attached and being furnished hereby as Exhibit 99.1 is a copy of a press release of International Flavors & Fragrances Inc. (“IFF” or the “Company”), dated November 4, 2025, reporting IFF’s financial results for the quarter ended September 30, 2025. A live webcast to discuss the Company’s third quarter 2025 financial results will be held on November 5, 2025, at 9:00 a.m. ET. The webcast and accompanying slide presentation may be accessed on the Co…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Pursuant to the previously disclosed Cooperation Agreement between International Flavors & Fragrances Inc. (the “Company”) and certain persons and entities collectively referred to as the Icahn Group (the “Icahn Group”), dated February 1, 2023 (the “Cooperation Agreement”), Icahn Capital LP (“Icahn Capital”) has requested that Mr. Brett Icahn repla…